🇬🇧 Saphris in United Kingdom

Saphris (ASENAPINE) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Sycrest
  • Status: approved

Saphris in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United Kingdom

Frequently asked questions

Is Saphris approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Saphris in United Kingdom?

Hisamitsu is the originator. The local marketing authorisation holder may differ — check the official source linked above.